Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A

Oncogene
S F RashidMoray J Campbell

Abstract

Prostate cancer is a major cause of male cancer death. In vitro and in vivo data support a role for 1 alpha,25 Dihydroxyvitamin D(3) (1 alpha,25(OH)(2)D(3)) in regulating the growth and differentiation of the normal prostate gland yet prostate cancer cells appear significantly less sensitive to this action. Vitamin D(3) receptor (VDR) content or mutational status do not correlate clearly with the antiproliferative effects of 1 alpha,25(OH)(2)D(3) and therefore it is unclear why prostate cancer cell lines are significantly less sensitive to this action. We hypothesized that the antiproliferative responses of prostate cancer cells to 1 alpha,25(OH)(2)D(3) are suppressed by a process involving histone deacetylation. Sodium butyrate (NaB) and trichostatin A (TSA) are inhibitors of histone deacetylase (HDAC) activity. Low doses of NaB or TSA (300 microM and 15 nM respectively), which alone were relatively inactive, synergized with 1 alpha,25(OH)(2)D(3) in liquid and semi-solid agar to inhibit the growth of LNCaP, PC-3 and DU-145 prostate cancer cells. Still greater synergy was observed between vitamin D(3) hexafluoride analogs and either NaB or TSA. The mechanism appeared to involve neither the cyclin-dependent kinase inhibitor, p21...Continue Reading

References

Mar 1, 1992·Molecular and Cellular Endocrinology·A C Maiyar, A W Norman
Jan 1, 1986·Leukemia Research·P KoistinenJ A Vilpo
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·W B IsaacsC M Ewing
Jan 1, 1993·The Prostate·A G CarrollE P Gelmann
Mar 1, 1993·Research in Veterinary Science·T TakahashiL A Devriese
Jul 1, 1996·British Journal of Cancer·Y TamimiJ A Schalken
Oct 1, 1996·Intensive Care Medicine·B J van der MeerP M de Vries
Jan 15, 1997·Journal of the National Cancer Institute·S A InglesG A Coetzee
Aug 1, 1997·Molecular Carcinogenesis·C W MillerH P Koeffler
Nov 14, 1997·The Biochemical Journal·S Nayeri, C Carlberg
Feb 5, 1998·CA: a Cancer Journal for Clinicians·D S Rosenthal
Feb 5, 1998·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Apr 7, 1998·Leukemia·S de VosH P Koeffler
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·H MiyamotoC Chang
Oct 23, 1998·Molecular and Cellular Endocrinology·L VerlindenR Bouillon
Apr 9, 1999·The Journal of Clinical Investigation·H HakonarsonM M Grunstein
May 14, 1999·Current Opinion in Genetics & Development·L XuM G Rosenfeld
Jun 25, 1999·Cell Death and Differentiation·C BowenE P Gelmann

❮ Previous
Next ❯

Citations

Sep 5, 2002·Medicinal Research Reviews·Roman A Blaheta, Jindrich Cinatl
Jul 31, 2004·Archives of Pharmacal Research·Ki Eun JoungYhun Yhong Sheen
May 31, 2013·Journal of Cardiovascular Translational Research·Oksan Gezmish, Mary Jane Black
Oct 29, 2003·Trends in Endocrinology and Metabolism : TEM·Tai C Chen, Michael F Holick
Apr 17, 2008·The Proceedings of the Nutrition Society·James Thorne, Moray J Campbell
Jan 20, 2005·Journal of the National Cancer Institute·Long-Cheng LiRajvir Dahiya
Mar 25, 2008·Acta Pharmacologica Sinica·Chun-gen XingZheng-hong Qin
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Daryl C DrummondChristopher C Benz
Nov 11, 2003·BMC Cancer·José Manuel Afonso MoreiraPoul Sørensen
Jun 23, 2011·Journal of Molecular Endocrinology·Eiji MunetsunaToshiyuki Sakaki
Jan 29, 2011·World Journal of Gastroenterology : WJG·Bao-Song ZhuZheng-Hong Qin
Apr 5, 2013·World Journal of Gastroenterology : WJG·Bao-Song ZhuChun-Gen Xing
Oct 25, 2012·International Journal of Nephrology·Jacob Hofman-BangEwa Lewin
Sep 20, 2006·Expert Opinion on Therapeutic Targets·Moray J Campbell, Luciano Adorini
Jun 24, 2015·Nutrients·Lorenza DíazIsabel Méndez
Oct 23, 2014·Journal of Cellular Physiology·Mark D LongMoray J Campbell
Jul 31, 2013·Progress in Histochemistry and Cytochemistry·Isabelle ClinckspoorBrigitte Decallonne
Aug 30, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Anna Woloszynska-ReadDonald L Trump
Mar 9, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Bo-Ying BaoYi-Fen Lee
Jun 23, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·David A GewirtzEden N Wilson
May 2, 2003·Annals of the New York Academy of Sciences·Sam ThiagalingamJose F Ponte
May 3, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Degui WangYingxia Tian
Dec 17, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Prashant K SinghMoray J Campbell
Jan 22, 2010·International Journal of Cancer. Journal International Du Cancer·Sebastiano BattagliaMoray J Campbell
Jan 25, 2005·The Journal of Steroid Biochemistry and Molecular Biology·Donna M Peehl, David Feldman
Jul 22, 2004·Experimental Cell Research·Michael Danilenko, George P Studzinski
Jul 1, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Lyndon M GommersallMoray J Campbell
Jul 1, 2004·The Journal of Steroid Biochemistry and Molecular Biology·Claire M BanwellMoray J Campbell
Mar 8, 2006·Urologic Oncology·Zhengwang ZhangJer-Tsong Hsieh
Mar 18, 2006·Toxicon : Official Journal of the International Society on Toxinology·Ci-Hui YanZheng-Hong Qin
Dec 2, 2005·Life Sciences·Kathleen M GilbertE Kim Fifer
Dec 12, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Sabine SeuterCarsten Carlberg
Oct 27, 2012·The Journal of Steroid Biochemistry and Molecular Biology·Prashant K SinghMoray J Campbell
Jun 7, 2015·Bioorganic & Medicinal Chemistry·Dainis KaldreJames L Gleason
May 27, 2014·Frontiers in Physiology·Moray J Campbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.